Checking PHAT unusual options activity helps you spot when traders are making outsized bets on Phathom Pharmaceuticals Inc before the broader market catches on. Phathom Pharmaceuticals Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor PHAT unusual options activity today and surface the prints that deserve a second look.
Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching PHAT unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking PHAT unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and PHAT unusual options flow data becomes especially valuable around earnings, product launches, and macro events.
Phathom Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company has the rights in the United States, Europe, and Canada to vonoprazan, a potassium-competitive acid blocker (P-CAB) that blocks acid secretion in the stomach. It is also developing vonoprazan, which is in Phase III clinical trials for the treatment of erosive gastroesophageal reflux disease; and in combination with antibiotics for the treatment of Helicobacter pylori infection. Phathom Pharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Florham Park, New Jersey.
Catalysts rarely arrive without a footprint, and PHAT unusual options activity is often where that footprint shows up first. Our scanner tracks Phathom Pharmaceuticals Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at PHAT unusual options volume on the call side or chasing put sweeps, Phathom Pharmaceuticals Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.
